Changing Profiles of Cardiovascular Disease and Risk Factors in China: a Secondary Analysis for the Global Burden of Disease Study 2019

Overview

Journal Chin Med J (Engl)

Specialty General Medicine

Date 2023 Jun 21

PMID 37341657

Authors

Huan Wang

Hao Zhang

Zhiyong Zou

Affiliations

Soon will be listed here.

Abstract

Background: Understanding the changing profiles of cardiovascular disease (CVD) and modifiable risk factors is essential for CVD prevention and control. We aimed to report the comprehensive trends in CVD and risk factors in China from 1990 to 2019.

Methods: Data on the incidence, death, and disability-adjusted life years (DALYs) of total CVD and its 11 subtypes for China were obtained from the Global Burden of Disease Study 2019. The CVD burden attributable to 12 risk factors was also retrieved. A secondary analysis was conducted to summarize the leading causes of CVD burden and attributable risk factors.

Results: From 1990 to 2019, the number of CVD incidence, death, and DALYs considerably increased by 132.8%, 89.1%, and 52.6%, respectively. Stroke, ischemic heart disease, and hypertensive heart disease accounted for over 95.0% of CVD deaths in 2019 and remained the top three causes during the past 30 years. Between 1990 and 2019, the age-standardized rate of stroke decreased significantly (percentage of decreased incidence: -9.3%; death: -39.8%; DALYs: -41.6%), while the rate of ischemic heart disease increased (percentage of increased incidence: 11.5%; death: 17.6%; DALYs: 2.2%). High systolic blood pressure, unhealthy diet, tobacco, and air pollution continued to be the major contributors to CVD deaths and DALYs (attributing to over 70% of the CVD burden), and the high body mass index (BMI)-associated CVD burden had the largest increase between 1990 and 2019.

Conclusions: The significant increases in the number of CVD incident cases, deaths, and DALYs suggest that the CVD burden is still a concern. Intensified strategies and policies are needed to maintain promising progress in stroke and to reduce the escalating burden of ischemic heart disease. The CVD burden attributable to risk factors has not yet made adequate achievements; even worse, high BMI has contributed to the increasing CVD burden.

Citing Articles

The relationship between frailty and major adverse cardiovascular and cerebrovascular events in Chinese older adults: the mediating effect of lipid accumulation products.

Kang Z, Ye Y, Xiao H, Liu L Arch Public Health. 2025; 83(1):33.

PMID: 39939980 PMC: 11817877. DOI: 10.1186/s13690-025-01520-8.

Characterisation of cardiovascular disease (CVD) incidence and machine learning risk prediction in middle-aged and elderly populations: data from the China health and retirement longitudinal study (CHARLS).

Huang Q, Jiang Z, Shi B, Meng J, Shu L, Hu F BMC Public Health. 2025; 25(1):518.

PMID: 39920658 PMC: 11806717. DOI: 10.1186/s12889-025-21609-7.

Advances in cardiac organoid research: implications for cardiovascular disease treatment.

Huang Z, Jia K, Tan Y, Yu Y, Xiao W, Zhou X Cardiovasc Diabetol. 2025; 24(1):25.

PMID: 39827092 PMC: 11743075. DOI: 10.1186/s12933-025-02598-8.

Construction and validation of coronary heart disease risk prediction model for general hospitals in Tacheng Prefecture, Xinjiang, China.

Xu Y, Ma J, Yang Y, Liu L, Zhao X, Wang Y Front Cardiovasc Med. 2024; 11:1514103.

PMID: 39735861 PMC: 11672339. DOI: 10.3389/fcvm.2024.1514103.

Moderate-intensity aerobic exercise inhibits cell pyroptosis to improve myocardial ischemia-reperfusion injury.

Wang Y, Li Y, Chen C, Zhang H, Liu W, Wu C Mol Biol Rep. 2024; 52(1):5.

PMID: 39570295 DOI: 10.1007/s11033-024-10065-y.

References

Tan X, Liu X, Shao H . Healthy China 2030: A Vision for Health Care. Value Health Reg Issues. 2017; 12:112-114. DOI: 10.1016/j.vhri.2017.04.001. View

. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1223-1249. PMC: 7566194. DOI: 10.1016/S0140-6736(20)30752-2. View

. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1160-1203. PMC: 7566045. DOI: 10.1016/S0140-6736(20)30977-6. View

Zhang M, Deng Q, Wang L, Huang Z, Zhou M, Li Y . Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults. Int J Cardiol. 2018; 260:196-203. DOI: 10.1016/j.ijcard.2017.12.069. View

Wang Y, Zhao L, Gao L, Pan A, Xue H . Health policy and public health implications of obesity in China. Lancet Diabetes Endocrinol. 2021; 9(7):446-461. DOI: 10.1016/S2213-8587(21)00118-2. View

Huang J, Pan X, Guo X, Li G . Health impact of China's Air Pollution Prevention and Control Action Plan: an analysis of national air quality monitoring and mortality data. Lancet Planet Health. 2018; 2(7):e313-e323. DOI: 10.1016/S2542-5196(18)30141-4. View

Ma S, Yang L, Zhao M, Magnussen C, Xi B . Trends in hypertension prevalence, awareness, treatment and control rates among Chinese adults, 1991-2015. J Hypertens. 2020; 39(4):740-748. DOI: 10.1097/HJH.0000000000002698. View

Pan X, Wang L, Pan A . Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021; 9(6):373-392. DOI: 10.1016/S2213-8587(21)00045-0. View

Li X, Wu C, Lu J, Chen B, Li Y, Yang Y . Cardiovascular risk factors in China: a nationwide population-based cohort study. Lancet Public Health. 2020; 5(12):e672-e681. DOI: 10.1016/S2468-2667(20)30191-2. View

10.

Roth G, Forouzanfar M, Moran A, Barber R, Nguyen G, Feigin V . Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015; 372(14):1333-41. PMC: 4482354. DOI: 10.1056/NEJMoa1406656. View

11.

Wang T, Zhao Z, Yu X, Zeng T, Xu M, Xu Y . Age-specific modifiable risk factor profiles for cardiovascular disease and all-cause mortality: a nationwide, population-based, prospective cohort study. Lancet Reg Health West Pac. 2022; 17:100277. PMC: 8720788. DOI: 10.1016/j.lanwpc.2021.100277. View

12.

Zhou Z, Hu D . An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol. 2008; 18(5):209-16. PMC: 4771592. DOI: 10.2188/jea.je2008021. View

13.

. Five insights from the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1135-1159. PMC: 7116361. DOI: 10.1016/S0140-6736(20)31404-5. View

14.

Pan X, Pan A . Dietary transitions and cardiometabolic health in China. Lancet Diabetes Endocrinol. 2019; 7(7):502-503. DOI: 10.1016/S2213-8587(19)30159-7. View

15.

Wang W, Wang D, Liu H, Sun H, Jiang B, Ru X . Trend of declining stroke mortality in China: reasons and analysis. Stroke Vasc Neurol. 2017; 2(3):132-139. PMC: 5628381. DOI: 10.1136/svn-2017-000098. View

16.

Gupta R, Wood D . Primary prevention of ischaemic heart disease: populations, individuals, and health professionals. Lancet. 2019; 394(10199):685-696. DOI: 10.1016/S0140-6736(19)31893-8. View

17.

Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson C . Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol. 2019; 18(4):394-405. DOI: 10.1016/S1474-4422(18)30500-3. View

18.

Chao B, Tu W, Wang L . Initial establishment of a stroke management model in China: 10 years (2011-2020) of Stroke Prevention Project Committee, National Health Commission. Chin Med J (Engl). 2021; 134(20):2418-2420. PMC: 8654431. DOI: 10.1097/CM9.0000000000001856. View

19.

Li Y, Wang D, Ley S, Howard A, He Y, Lu Y . Potential Impact of Time Trend of Life-Style Factors on Cardiovascular Disease Burden in China. J Am Coll Cardiol. 2016; 68(8):818-33. PMC: 5850940. DOI: 10.1016/j.jacc.2016.06.011. View

20.

Chao B, Yan F, Hua Y, Liu J, Yang Y, Ji X . Stroke prevention and control system in China: CSPPC-Stroke Program. Int J Stroke. 2020; 16(3):265-272. DOI: 10.1177/1747493020913557. View